Patient P-02470
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
47%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S11
- Day 12 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 12.
Primary contributors, last 14 days
- GI instability+21
- Nutritional resilience-7
- Inflammatory activity+3
- Toxicity-3
- Treatment adherence-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable45 min
stable · +0.6 vs previous 14 d
Sleep duration
Wearable5.5 h
improving · +0.2 vs previous 14 d
Energy level
Daily log5.1/10
improving · +0.7 vs previous 14 d
Steps
Wearable5,246
stable · -71 vs previous 14 d
GI burden
Companion35.1/100
improving · -9.3 vs previous 14 d
Adherence
Companion92.4 %
stable · -0.7 vs previous 14 d
Sleep quality
Wearable35.4/100
improving · +7.3 vs previous 14 d
Glucose, CGM daily mean
CGM134 mg/dL
improving · -5.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 61 from the failing basin, 26 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -5.8 next day on high-intake days · n 18
Would not help
- Keep fat lowGI +6.3 next day on high-intake days · n 23
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Dietary fat load+6.3detractor · 95%
- Protein-5.8supporter · 95%
- Caffeine-2.7no signal · 43%
- Simple carbohydrates+2.5no signal · 39%
- Alcohol+2.5no signal · 34%
- Insoluble fibre-1.9no signal · 30%
- Ultra-processed food-1.3no signal · 21%
- Histamine load-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓45
- WearableResting HR 73 bpm
- WearableShort sleep window
- Mucosal barrier integrity ↓40
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 5.5 h, below personal baseline
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 41/100
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.2 · butyrate capacity 41/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 64 ms
- Sleep
- 6.2 h
- Steps
- 5,433
- Resting HR
- 69 bpm
Daily log: GI score 35, nutritional resilience 60, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02031 | 33% | S12 | AD-05 | improved | 47 |
| P-02093 | 33% | S05 | AD-05 | no change | 40 |
| P-02285 | 32% | S14 | AD-05 | no change | 39 |
| P-02483 | 40% | S06 | BR-03 | no change | 64 |
| P-02087 | 36% | S01 | BR-03 | no change | 40 |
| P-02280 | 35% | S07 | BR-03 | no change | 50 |
| P-02267 | 33% | S09 | BR-03 | no change | 45 |
| P-02522 | 33% | S01 | BR-03 | no change | 40 |
| P-02638 | 32% | S01 | BR-03 | improved | 41 |
| P-02354 | 33% | S01 | CR-01 | improved | 78 |
| P-02218 | 47% | S01 | DT-01 | improved | 61 |
| P-02479 | 45% | S13 | DT-01 | improved | 48 |